Zomedica Corp. (ZOMDF)

Zomedica Revenue

Zomedica had revenue of $9.90M in the quarter ending September 30, 2026, with 22.29% growth. This brings the company's total for the last twelve months to $38.68M, up 31.33% year-over-year. In the year 2025, Zomedica had annual revenue of $32.03M with 17.39% growth. That makes Zomedica the 29,741st largest company in the world by revenue and 3,948th in the United States.

• Revenue (ttm): 38.68M
• Revenue Growth: +31.33%
• P/S Ratio: 2.39
• Revenue / Employee: 274.33K
• Employees: 141
• Market Cap: 95.10M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Therapeutics Devices 26.20M 81.8%
• Development Services 3.03M 9.5%
• Diagnostics 2.80M 8.7%

By Geography

Chart

• United States 26.46M 82.6%
• Foreign 5.57M 17.4%

Fiscal year ended Dec 31, 2025 See the full Zomedica breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	32.03M	4.75M	17.39%
Dec 31, 2024	27.29M	2.10M	8.33%
Dec 31, 2023	25.19M	6.26M	33.05%
Dec 31, 2022	18.93M	14.80M	358.02%
Dec 31, 2021	4.13M	-	-

Data Source: S&P Global Market Intelligence Last updated: Nov 4, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error